- Home
- GDTC vs INLF Comparison
GDTC vs INLF Comparison
Compare GDTC & INLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- INLF
- Stock Information
- Founded
- GDTC 2018
- INLF 2016
- Country
- GDTC Singapore
- INLF China
- Employees
- GDTC N/A
- INLF N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- INLF Industrial Machinery/Components
- Sector
- GDTC Health Care
- INLF Industrials
- Exchange
- GDTC Nasdaq
- INLF Nasdaq
- Market Cap
- GDTC 21.5M
- INLF 19.2M
- IPO Year
- GDTC 2023
- INLF 2025
- Fundamental
- Price
- GDTC $2.03
- INLF $0.87
- Analyst Decision
- GDTC Buy
- INLF
- Analyst Count
- GDTC 1
- INLF 0
- Target Price
- GDTC $5.00
- INLF N/A
- AVG Volume (30 Days)
- GDTC 13.2K
- INLF 424.6K
- Earning Date
- GDTC 01-01-0001
- INLF 01-01-0001
- Dividend Yield
- GDTC N/A
- INLF N/A
- EPS Growth
- GDTC N/A
- INLF 18.78
- EPS
- GDTC N/A
- INLF 0.13
- Revenue
- GDTC $368,838.00
- INLF $15,796,983.00
- Revenue This Year
- GDTC $5.37
- INLF N/A
- Revenue Next Year
- GDTC N/A
- INLF N/A
- P/E Ratio
- GDTC N/A
- INLF $7.32
- Revenue Growth
- GDTC N/A
- INLF 25.27
- 52 Week Low
- GDTC $1.20
- INLF $0.77
- 52 Week High
- GDTC $4.05
- INLF $21.00
- Technical
- Relative Strength Index (RSI)
- GDTC 51.85
- INLF 37.00
- Support Level
- GDTC N/A
- INLF $0.86
- Resistance Level
- GDTC $2.27
- INLF $1.05
- Average True Range (ATR)
- GDTC 0.10
- INLF 0.09
- MACD
- GDTC -0.06
- INLF -0.02
- Stochastic Oscillator
- GDTC 87.67
- INLF 17.78
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About INLF INLIF LIMITED Ordinary Shares
INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.